Volume 75, Issue 10, Pages (May 2009)

Slides:



Advertisements
Similar presentations
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Advertisements

Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Improved prognosis of diabetic nephropathy in type 1 diabetes
Chronic Kidney Disease in Diabetes
Melody Sherwood, Peter A McCullough  The Lancet Global Health 
Volume 80, Issue 1, Pages (July 2011)
Volume 67, Pages S1-S7 (June 2005)
Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation  Jordi Bover,
Volume 67, Issue 6, Pages (June 2005)
Volume 80, Issue 1, Pages (July 2011)
CKD: Common, Harmful, and Treatable—World Kidney Day 2007
Frederik Persson, Peter Rossing  Kidney International Supplements 
Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician  Joseph A. Vassalotti, MD, Robert Centor, MD,
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Volume 83, Issue 3, Pages (March 2013)
Section 2: AKI Definition
Kidney International Supplements 
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Summary of Recommendation Statements
A Decade After the KDOQI CKD Guidelines
Shining light on vitamin D trials in chronic kidney disease
Volume 80, Issue 9, (November 2011)
Prehypertension and chronic kidney disease: the ox or the plow?
The urinary metabolome of chronic kidney disease
Reassessment of the care of the patient with chronic kidney disease
Volume 80, Issue 1, Pages (July 2011)
Melody Sherwood, Peter A McCullough  The Lancet Global Health 
John P. Middleton, Patrick H. Pun  Kidney International 
Chapter 3: Management of progression and complications of CKD
Chapter 5: Referral to specialists and models of care
Volume 86, Issue 4, Pages (October 2014)
Volume 72, Issue 10, Pages (November 2007)
Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the.
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Meeting the challenges of the new K/DOQI guidelines
Volume 79, Issue 12, Pages (June 2011)
Volume 77, Issue 1, Pages 5-6 (January 2010)
Comorbidity and confounding in end-stage renal disease
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
A Decade After the KDOQI CKD Guidelines: A Historical Perspective
Volume 70, Issue 11, Pages (December 2006)
Volume 88, Issue 5, Pages (November 2015)
Predicting an allograft's fate
American Journal of Kidney Diseases
Volume 75, Issue 1, Pages (January 2009)
U-shaped effect of eGFR and mortality
Nephrology: As It Was Then, But Is Not Now
Volume 73, Issue 12, Pages (June 2008)
Volume 81, Issue 6, Pages (March 2012)
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Evidence and Outcomes in CKD
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Methods for guideline development
Volume 76, Issue 8, Pages (October 2009)
Cardiovascular risk factors in chronic kidney disease
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 85, Issue 5, Pages (May 2014)
Volume 80, Issue 3, Pages (August 2011)
Volume 80, Issue 12, Pages (December 2011)
Volume 72, Issue 3, Pages (August 2007)
Volume 60, Issue 1, Pages (July 2001)
Volume 76, Issue 6, Pages (September 2009)
Volume 80, Issue 10, Pages (November 2011)
Introduction: The case for updating and context
Conceptual model of the course of chronic kidney disease (CKD).
Volume 87, Issue 3, Pages (March 2015)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
The Ebf1 knockout mouse and glomerular maturation
Sugar-sweetened beverages and chronic disease
Presentation transcript:

Volume 75, Issue 10, Pages 1015-1018 (May 2009) Chronic kidney disease definition and classification: no need for a rush to judgment  Garabed Eknoyan  Kidney International  Volume 75, Issue 10, Pages 1015-1018 (May 2009) DOI: 10.1038/ki.2009.53 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Conceptual model of the course and outcomes of chronic kidney disease. The ellipses represent the potential changing stages and consequences of chronic kidney disease (CKD). The first two open ellipses are antecedents and determinants of the increased risk for CKD. The next two ellipses are flagged for albuminuria and an estimated glomerular filtration rate of <60 ml/min per 1.73 m2, the two determinants for the definition and detection of CKD. The green ellipse at the top refers to complications that can develop at each stage of CKD (hypertension, anemia, mineral, and bone disorders) and their treatment (drug side effects). The gradually increasing thickness of the blue arrows connecting the ellipses represent the relative risk of the potential for progression and that of potential complications. The dotted blue arrows connecting the ellipses indicate the potential for improvements in albuminuria and glomerular filtration rate, because of treatment or variable natural history of the primary kidney disease. The thicker red arrows at the bottom indicate the increasing risk for all-cause mortality, principally because of cardiovascular disease; and their relative sizes represent the increasing risks of death at each progressive stage of CKD. The figure fails to show that many cases fail to progress or regress and remain at the same stage as when first detected. GFR, glomerular filtration rate. Reprinted with permission from reference 16. Kidney International 2009 75, 1015-1018DOI: (10.1038/ki.2009.53) Copyright © 2009 International Society of Nephrology Terms and Conditions